One Strain. Three Designations. Complete Chain of Evidence - from DSMZ deposition through the Budapest Treaty to the registered EU trademark.
All three designations refer to the same bacterial strain. Identity confirmed by Whole-Genome Sequencing (CeGaT GmbH, 27 January 2022): DSM 21097 and DSM 33619 are genetically identical.
Individual deposition number at the German Collection of Microorganisms and Cell Cultures (DSMZ) in Braunschweig. The original scientific reference number for the strain.
International patent deposition under the Budapest Treaty (20 August 2020). This number secures the patent protection of the strain and forms the basis for the granted European Patent EP 3 964 195.
Registered EU word mark No. 018279328 (registered 27 February 2021). Nice Classes 1, 5, 32 - the commercial brand name for scientific publications and the B2B market.
Consistent use of the brand name MM40® across publications, documents and communication - for uniform recognition and traceability.
| Context | Designation | Example |
|---|---|---|
| First mention | Full form | "Bacillus subtilis DSM 21097 (international patent deposit DSM 33619; commercially designated as Bacillus subtilis MM40)" |
| Technical / Methods | Full strain ID | "B. subtilis DSM 21097 (Budapest Treaty: DSM 33619; EU trademark No. 018279328)" |
| General text | Short form | "MM40" or "B. subtilis MM40" |
| References | Full form | "B. subtilis MM40 (DSM 21097/DSM 33619)" |
The MM40® strain designation is supported by a complete chain of official documents - from international patent deposition to the granted European Patent.
Antimicrobial activity documented
International patent deposition
Registered word mark "Bacillus subtilis MM40"
Genetic proof: identical strain
Patented active complex
Topical application documented
The consistent use of the commercial name MM40 in scientific literature aims to firmly link the brand name with published evidence - comparable to Calsporin® (B. subtilis C-3102) or DE111® (B. subtilis DE111).
Every citation carries the MM40 name into the scientific community.
Complete chain of evidence from DSM numbers, Budapest Treaty deposition, and EU trademark.
Consistent naming for future approval procedures (Novel Food, Feed Additive).
MM40 positions itself as an independent, characterized brand versus generic B. subtilis strains.
Explore the scientific evidence behind the strain or speak directly with our team about partnership opportunities.
